Implantable device revolutionizes thyroid management

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time.

Ono Pharmaceutical partners with EME for antibody drug discovery

Share this article Ono will carry out testing to assess the in vitro and in vivo assay activities of the antibodies. Credit: Alexander Raths /

February 22, 2024

Revolutionary four-biomarker panel offers hope for early ovarian cancer detection

The biomarker CA125 for early detection of ovarian cancer.

January 11, 2024

To regrow blood vessels after heart attack, a little transplant of mitochondria goes a long way in mice

Blood vessels in the legs or heart sustain considerable damage when they are narrowed by poor circulation from diabetes or blocked in a heart attack.

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.